Using advanced imaging to guide early liver cancer treatment
Part of Cancer, Digestive system clinical trials.
This study uses advanced imaging (MRI and contrast-enhanced ultrasound) with computer technology to help doctors decide the best treatment for early-stage liver cancer. It aims to improve outcomes for patients who undergo surgery or microwave ablation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of liver cancer (hepatocellular carcinoma) confirmed by imaging or biopsy.
- You need to be in early stages of liver cancer (stage I or IIa) and have a well-functioning liver (Child-Pugh class A or B).
- The size and number of tumors matter: either one tumor of 5 cm or smaller, or 2 to 3 tumors with the largest one 3 cm or smaller.
- You should be planning to have either surgery to remove the tumor or a minimally invasive treatment called microwave ablation.
- You need to have had an MRI or a contrast-enhanced ultrasound within the last month before your surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a computer-guided microwave ablation procedure to destroy liver tumors. If you have early-stage liver cancer with up to 5 tumors, and one is 2-5 cm in size, you may be a candidate.
This study aims to improve how doctors diagnose and treat liver cancer by combining advanced imaging tests and genetic analysis. It may help in choosing the most effective treatment for each person.
This study compares two types of microwave ablation (a heat-based treatment that destroys tumors) with standard surgery for liver cancer tumors that sit near the surface of the liver. The goal is to see which treatment is safer and works better for people whose tumors are close to the liver's outer edge.
This study compares two imaging methods, ultrasound and MRI, to see which is better at finding liver cancer early in people who are at high risk. Early detection could lead to more effective treatment and better outcomes.
This study uses digital scans of your tumor tissue and CT/MRI images to build a computer model that helps predict whether you might need extra treatment (adjuvant therapy) after liver cancer surgery. The goal is to use your own tissue and scan data to personalize follow-up care.
This study tests a new, more detailed ultrasound technique to better see liver tumors. It may help doctors understand your tumor better without extra procedures.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.